Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

PHASE3CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

April 22, 2015

Primary Completion Date

February 25, 2016

Study Completion Date

February 29, 2016

Conditions

Hypertension

Interventions

DRUG

Candesartan 16mg

DRUG

Amlodipine 5mg

DRUG

Amlodipine 10mg

Trial Locations (1)

Severance Hospital, Seoul